FDA Diabetes Drug Inquiry Finds No Cancer Risks
The U.S. Food and Drug Administration said Wednesday it has found no evidence that a class of diabetes drugs made by Merck & Co. Inc., Bristol-Myers Squibb Co. and others is...To view the full article, register now.
Already a subscriber? Click here to view full article